AFC
GILD icon

AFT Forsyth & Company’s Gilead Sciences GILD Stock Holding History

AFT Forsyth & Company’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$54K Hold
866
– – 0.07% 171
2013
Q2 		$44K Buy
+866
New +$45.1K 0.06% 172

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AFT Forsyth & Company's GILD Position: Q3 2013 in Review

AFT Forsyth & Company held its Gilead Sciences (GILD) position steady in Q3 2013 at 866 shares worth $54K. The position accounts for 0.07% of the portfolio, ranked #171.

AFT Forsyth & Company first reported a position in GILD in Q2 2013 and has held it in 2 quarters since. 982 funds tracked by Wall St. Rank hold GILD as of Q3 2013.

  • AFT Forsyth & Company held 866 shares of Gilead Sciences worth $54K as of Q3 2013.
  • AFT Forsyth & Company left its Gilead Sciences share count unchanged in Q3 2013.
  • Gilead Sciences made up 0.07% of AFT Forsyth & Company's portfolio in Q3 2013, its #171 holding.
  • AFT Forsyth & Company first reported a position in Gilead Sciences in Q2 2013 and has held it in 2 quarters since.
  • 982 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2013.

Based on AFT Forsyth & Company's 13F filing for Q3 2013, filed 8 Nov 2013.